E78.71

Clinical Causes: Mutations in the TAZ gene, which is responsible for producing a protein necessary for normal mitochondrial function Inheritance pattern: X-linked recessive, meaning the gene mutation occurs on the X chromosome, often passed from mothers to their sons No known environmental factors directly cause Barth syndrome

Key Symptoms: Heart problems like cardiomyopathy, which can cause heart failure or arrhythmias Low levels of certain blood cells called neutrophils, leading to increased risk of infections Growth delays and failure to thrive in infants and children Muscle weakness and fatigue Distinctive facial features that may include prominent cheeks and a somewhat elongated face Increased levels of organic acids in the blood and urine, affecting metabolism Other features such as feeding difficulties, delayed motor development, and developmental delays

Diagnosis Path: Diagnosis involves a combination of clinical assessments and laboratory tests. These may include genetic testing to identify mutations in the TAZ gene, blood tests to evaluate blood cell counts and metabolic profiles, and echocardiography to assess heart function. Due to the rarity of the condition, diagnosis can be challenging and may require specialist consultation.

Treatment Protocols: There is currently no cure for Barth syndrome. Treatment is focused on managing symptoms and preventing complications. This may involve: - Medications to support heart function and address arrhythmias - Antibiotics or other therapies to reduce infection risk during neutropenic episodes - Nutritional support to promote growth - Regular monitoring of heart health and blood cell counts - Multidisciplinary care, including cardiologists, hematologists, and nutritionists, to address the complex needs of affected individuals